1. Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials. Issue 3 (March 2022) Authors: Bradley, Rosie; Braybrooke, Jeremy; Gray, Richard; Hills, Robert K; Liu, Zulian; Pan, Hongchao; Peto, Richard; Dodwell, David; McGale, Paul; Taylor, Carolyn; Francis, Prudence A; Gnant, Michael; Perrone, Francesco; Regan, Meredith M; Berry, Richard; Boddington, Clare; Clarke, Mike; Davies, Christ... Journal: Lancet oncology Issue: Volume 23:Issue 3(2022) Page Start: 382 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. Issue 10179 (6th April 2019) Authors: Gray, Richard; Bradley, Rosie; Braybrooke, Jeremy; Liu, Zulian; Peto, Richard; Davies, Lucy; Dodwell, David; McGale, Paul; Pan, Hongchao; Taylor, Carolyn; Barlow, William; Bliss, Judith; Bruzzi, Paolo; Cameron, David; Fountzilas, George; Loibl, Sibylle; Mackey, John; Martin, Miguel; Del Mastro, L... Journal: Lancet Issue: Volume 393:Issue 10179(2019) Page Start: 1440 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗